Gene · 1585
Papers3,065
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,065
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging Medical Therapies for Primary Aldosteronism. | Hypertension | 2026 | 41685462 | PubTator, text mining | PubMed |
| Steroidogenesis in Pediatric Adrenal Rests in the Spermatic Cord. | J Surg Res | 2026 | 41671598 | PubTator, text mining | PubMed |
| Pooled diagnostic accuracy of 68Ga-pentixafor PET/CT for aldosterone-producing lesions in primary aldosteronism. | Clin Imaging | 2026 | 41653499 | PubTator, text mining | PubMed |
| Aldosterone synthase inhibitors for resistant or uncontrolled hypertension: a network meta-analysis of randomized clinical trials. | J Hypertens | 2026 | 41645642 | PubTator, text mining | PubMed |
| Aldosterone: Synthesis and regulation. | Vitam Horm | 2026 | 41638796 | PubTator, text mining | PubMed |
| Aldosterone-mineralocorticoid receptor interactions: new insights and therapeutic perspectives in primary aldosteronism. | Hypertens Res | 2026 | 41629686 | PubTator, text mining | PubMed |
| Adrenal histologic and genetic characteristics of primary aldosteronism in late adulthood. | Eur J Endocrinol | 2026 | 41618603 | PubTator, text mining | PubMed |
| Evolving Mineralocorticoid Receptor Antagonism: a Narrative Review on Differences between Steroidal MRAs, Non-Steroidal MRAs and Aldosterone Synthase Inhibitors in Cardiorenal Disease. | Curr Heart Fail Rep | 2026 | 41615644 | PubTator, text mining | PubMed |
| Premature coronary artery disease in women: sex-specific risk factors, pathogenetic mechanisms and clinical implications. | Ann Med | 2026 | 41614676 | PubTator, text mining | PubMed |
| New pharmacological therapies for hypertension. | Curr Opin Nephrol Hypertens | 2026 | 41601463 | PubTator, text mining | PubMed |
| The role of arachidonic acid metabolites in the subtype classification and pathogenesis of primary aldosteronism. | iScience | 2026 | 41585488 | PubTator, text mining | PubMed |
| Altitude hypoxia and hypoxemia: pathogenesis and management. | Signal Transduct Target Ther | 2026 | 41571626 | PubTator, text mining | PubMed |
| Daily Sodium Intake Based on Random Urinary Excretion in Children Aged 6-24 Months and Associated Risk Factors. | Pediatr Gastroenterol Hepatol Nutr | 2026 | 41567254 | PubTator, text mining | PubMed |
| Transporter-transporter interplay determines the renal-predominant elimination of the O-glucuronide metabolite (BI 689875) of vicadrostat in humans. | Drug Metab Dispos | 2026 | 41539159 | PubTator, text mining | PubMed |
| Non-invasive Prediction of CYP11B2-Defined Subtypes in Primary Aldosteronism Using 18F-Pentixafor PET/CT and Machine Learning. | Acad Radiol | 2026 | 41530023 | PubTator, text mining | PubMed |
| A novel 2D and 3D model for primary adrenocortical carcinoma of advanced and metastasized stage co-secreting cortisol, aldosterone, testosterone, 18-oxocortisol and 18-hydroxycortisol. | Endocr Relat Cancer | 2026 | 41528016 | PubTator, text mining | PubMed |
| Next-generation therapeutics for diabetic kidney disease. | Nat Rev Nephrol | 2026 | 41526484 | PubTator, text mining | PubMed |
| Somatic Drivers in Aldosterone-producing Adenomas and Nodules: Insights from a Brazilian Cohort of Primary Aldosteronism. | J Clin Endocrinol Metab | 2026 | 41498208 | PubTator, text mining | PubMed |
| Renalase stimulates aldosterone production via PMCA4b/cAMP in NCI-H295R cells. | J Enzyme Inhib Med Chem | 2026 | 41495987 | PubTator, text mining | PubMed |
| Nephrology highlights in 2025: Diagnostic and therapeutic advances and emerging challenges | Nephrol Ther | 2026 | 41493087 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1585/papers?page=6